chrisvoncsefalvay/vaers-outcomes huggingface dataset:
throat pain; joint paint; fever (2-3 weeks duration); rash; Blood work showed high Ferritin (2000+); Blood work showed high Ferritin (2000+), WBC, CRP, Sed Rate and elevated platelets; Blood work showed high Ferritin (2000+), WBC, CRP, Sed Rate and elevated platelets.; elevated platelets; I was diagnosed with Adult Onset Still's disease; Sed rate high; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 23Mar2021 13:00 at the age of 34 years old (Lot Number: ER8730) as DOSE 2, SINGLE for covid-19 immunisation. Medical history was reported as none. There were no concomitant medications. The facility where the most recent COVID-19 vaccine was administered in Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been COVID-9 tested since the vaccination. The patient previously had BNT162B2 dose 1, (lot number: EN6204) on 02Mar2021 at 01:30 PM in the left arm for COVID-19 immunisation at the age of 34 years old. The patient stated, "In the beginning of Jun2021, I developed a throat pain, joint paint, fever (2-3 weeks duration) and a rash. Blood work showed high Ferritin (2000+), WBC, CRP, Sed Rate and elevated platelets. After two hospital visits where infections as the cause of my symptoms were ruled out, I was diagnosed with Adult Onset Still's Disease. The events started on 05Jun2021 08:00. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events resulted in 8 days hospitalization: 8. the patient received treatment NSAIDS and steroids for the adverse events. The patient underwent lab tests and procedures which included PCR Nasal Swab negative on 07Jun2021, 21Jun2021 and 09Jul2021. Sed rate high in Jun2021, ferritin 2000+ high in Jun2021, WBC high in Jun2021, CRP high in Jun2021 and platelets elevated in Jun2021. The outcome of events was not recovered.
Vertigo - horrible dizziness and nausea 36 hours after shot that caused me to go to the hospital by ambulance. Felt symptoms for 2 days, but now continue to get intermittent vertigo,(1-2x/month) which I have never had in my life prior to the booster.
Patient developed shakiness, chills, and headache apx. 12 hours after the flu vaccine.  They overall improved.  No s/s of anaphylactic reaction.
no sense of taste/could 't taste anything; This is a spontaneous report from a contactable consumer (patient). A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6205), dose 2 via an unspecified route of administration on 26Feb2021 (at the age of 61-years-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history was none. Concomitant medication included thyroid Pill (that's the only thing she take). Previously, the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6201), dose 1 via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. Reportedly, the patient received second dose of the Covid vaccine on 26Feb2021 (Friday), and the following Monday, on 01Mar2021 she had no sense of taste, and she lost her sense of taste and it's been about a week. The patient underwent lab work on 26Feb2021 and there was no issue with the results. No treatment received, just noticed that she could smell but she could 't taste anything, it's been about a week. That' the only side effect that she had. The patient asked if that was a normal side effect of the vaccine and if she should get a Covid test. Outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Pt was laid down on exam table for her vaccine as she reported a h/o passing out prev. from a vaccine. The vaccine was given into her LA & she was breathing slow & deep as instructed. Passed out. Hypotonic. Deep rapid resps followed by brief apnea. VS 4:00 148/80, HR 120, 4:05 144/80, HR 96, 4:10 146/92 & amb arrived on scene with pt to ER.
Flu like symptoms after the second dose; body aches; sweaty; Diarrhea; Lump under right arm; Peeling on hands and feet; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received bnt162b2, dose 2 via an unspecified route of administration, administered in right arm on 08Apr2021 (Lot Number: Ew0158) as dose 2, single at the age of 38-year-old for COVID-19 immunisation. Medical history included known allergies: Sulfa. The patient was not pregnant. Concomitant medications included fluconazole; cyanocobalamin (B 12); clindamycin hydrochloride (CLEOCIN); antibiotics in two weeks. Historic vaccine was bnt162b2 received via an unknown route of administration, administered in right arm on 18Mar2021 15:45 (lot number Er2613) at the age of 38-year-old for COVID-19 immunisation. No other vaccine in four weeks. The patient experienced flu like symptoms, body aches, sweaty, diarrhea, lump under right arm, peeling on hands and feet on 09Apr2021 04:00. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if treatment received. No COVID prior vaccination. No COVID tested post vaccination. The outcome of events was recovered with sequelae in 2021.  No follow-up attempts are needed. No further information is expected.
one day she did run a fever; horrible sinus infection, the whole side of her head was stopped up; a little bit short of breath; she didn't have a rash but she itched all over; her arms and legs felt like they were swelling; she had a headache; she was very tired; the joint pain was awful; hurting so bad; the muscles in her hips and everything was really tight; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ENOL98), via an unspecified route of administration on 12Jul2021 01:00 (at the age of 74-year-old) as dose 1, single for covid-19 immunization. There were no medical history and concomitant medications. About an hour and a half after she had the COVID vaccine on 12Jul2021, she was a little bit short of breath, she didn't have a rash but she itched all over, her arms and legs felt like they were swelling, she had a headache, she was very tired, the joint pain was awful and one day she did run a fever. The funny thing about it was that the site where they gave the COVID vaccine to her never swelled. She will not be getting the second shot. She says these began about an hour or an hour and a half afterwards. She doesn't have a normal body because she stayed for the whole 15 minutes and nothing happened and she thought, oh heck, so she had gone to grocery store and the longer she was there she got to feeling worse. So she thought that she needed to get home. When she got home she started itching and if there's something in body that it doesn't like she itches. She couldn't get hot, she had to stay cold, her husband was thinking about moving outside because it was so cold in there. Probed if she was still experiencing these to today and she say that it took about a week for them to go away. The joint pain went away in about 4 days, it's like it pulled at her back, it was horrible, the muscles in her hips and everything was really tight. It was about 4 days and by looking at the calendar she says it was either Friday or Thursday (Jul2021). She clarifies and says that by Thursday it was easing off including the joint pain and it all went away by Monday, 19Jul2021. It was so awful that she couldn't even sit in a chair, she had to go lay down because she was hurting so bad. Fever was on 15Jul2021 and then she woke up the next morning with a horrible sinus infection, the whole side of her head was stopped up and the fever lasted about an hour. Horrible sinus infection began on 13Jul2021, the next day after her COVID vaccine. She had antibiotics in case it did start and when it did she started taking those and then got rid of that. Caller confirms that her fever was 15Jul2021 and that the sinus infection started 13Jul2021, the day after her COVID vaccine which was given on 12Jul2021. Outcome of the event fever was recovered on 15Jul2021; sinus infection was recovered on an unspecified date in Jul2021; pain was unknown; other events was recovered on 19Jul2021.  Follow-up attempts are completed. No further information is expected.
Patient received first dose of pfizer vaccine, approximately 10 mins following administration, patient reported feeling dizzy/lightheaded, palpitations. Blood pressure and heart rate were taken immediately and were 138/90 and 86 respectively. Patient was advised to continue sitting and given water.  Blood pressure and heart were monitored every 5-10 mins. Patient remained sitting near pharmacy with continued symptoms for over 60 mins. Due to symptoms not resolving family took patient to urgent care to be assessed.
5.25cm x 5.25cm RASH AT INJECTION SITE.  RASH IS ITCHY, SWOLLEN, AND WARM TO TOUCH.
Varicella symptoms - occuring 5-28-04, general malaise, 5-29-04 low grade temp. 05-30-04 temp 101, macule, paule, vesicular, pustular lesions, upper torso and face and legs 725 lesions - dry lesions in 5-6 days.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Mar2021 as dose number unknown, single (Batch/Lot number: unknown), in right arm and on 16Apr2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 34 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: bees" (unspecified if ongoing); "known allergies: Cranberries" (unspecified if ongoing); "known allergies: Coconut" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Ambien, reaction(s): "known allergies: Ambien"; Codeine, reaction(s): "known allergies: Codeine"; Vancomycin, reaction(s): "known allergies: Vancomycin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: The lot number was unknown since unable to get. The patient received Paxlovid for COVID 19 treatment. The patient had known allergies Ambien, Codeine, Clarinex,Vancomycin, Coconut, Cranberries, bees.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On first shot about 6to days later I had double vision on right eye for about an hour and then very bright vision followed by not feeling well for another hour.Then it all went away.Second shot about 6 days later I feel a spongy feeling in my face followed by tingling and numbness in face. Went to emergency room as they thought I had a TIA after the first shot but suggested I get the second shot anyway. I have had ct scan, mri and eye?s checked since second episode.  It?s been more than a month and still have numbness on left side of face. Eye doctor suggested it might not have been a TIA but rather Gillian Barre syndrome. At my work was mandated to take the vaccine and still suffering from the second shot more than a month later. I will not take the third booster
SEVERE DIARRHEA; NAUSEA; A spontaneous case report was received from a nurse on 11-Nov-2019 for two consumers. Additional information was received on 13-Nov-2019.  Based on the information obtained from the nurse, two individual case safety report PVX201911-000856 (PVX2019-2787; female) and PVX201911-000857 (PVX2019-2788; male) were created and cross-linked in the database.  The case report (PVX2019-2788) described a 77-year-old elderly male consumer who had nausea (PT: Nausea) and severe diarrhea (PT: Diarrhoea), while being on oral Vivotif (took one capsule every other day) for typhoid fever prophylaxis.   Case report: The consumer took Vivotif doses on 16-Oct-2019, 18-Oct-2019, 20-Oct-2019, and 22-Oct-2019. It was reported that the consumer was still complaining of nausea and severe diarrhea. As of 11-Nov-2019, the events were ongoing which were interfering with his daily life.  Past medication history included Yellow fever vaccine and a Tetanus vaccine, which were taken on 09-Oct-2019.  Action taken with Vivotif with respect to reported events was unknown.  The consumer had not recovered from the reported events.  Company's Comment: In this case, it was reported that a male consumer developed severe uncontrollable diarrhea and nausea following administration of Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. Also, diarrhoea and nausea are labelled as per CCDS. Hence, the causality of the events with Vivotif is assessed as possible.; Sender's Comments: Company's Comment: In this case, it was reported that a male consumer developed severe uncontrollable diarrhea and nausea following administration of  of Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. Also, diarrhoea and nausea are labelled as per CCDS. Hence, the causality of the events with Vivotif is assessed as possible. US-PaxVax Berna GmbH-PVX201911-000856:
Weakness in left arm 18 hours after vaccine administration; Also tingling pain and numbness with excessive sensitivity in left hand; Also tingling pain and numbness with excessive sensitivity in left hand; Also tingling pain and numbness with excessive sensitivity in left hand; Also tingling pain and numbness with excessive sensitivity in left hand; This is a spontaneous report from a contactable consumer. This 67-year-old male consumer (patient) received 2nd dose of BNT162B2 (Lot # EN6203), on 24Feb2021 09:30 AM, vaccine location in Left arm for covid-19 immunization (at the age of 66 years old). Medical history included osteoarthritis, osteoporosis, prostate cancer, cancer in remission. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Historical vaccine was 1st dose of BNT162B2 (LOT # EL9264), on 03Feb2021 12:00 PM, vaccine location in Left arm for covid-19 immunization. Patient experienced Weakness in left arm 18 hours after vaccine administration. Also tingling pain and numbness with excessive sensitivity in left hand which has not subsided from 25Feb2021. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Outcome of the event was Not recovered.  No follow-up attempts possible. No further information expected.
Information has been received from an advanced practice registered nurse (A.P.R.N) concerning a 20 year old female patient, who on 23-MAY-2011 was vaccinated intramuscularly with a 0.5 ml dose of GARDASIL (lot #669265/0181AA). Advance practice registered nurse, stated that the patient developed an injection site rash on her left arm after receiving GARDASIL. The nurse noted that the rash spread to the patient's upper left  arm but no fever was present. The nurse stated that the patient reported this rash on 28-MAY-2011, five days after GARDASIL was administered, but she believed that the rash developed on the same date the GARDASIL was given. ZYRTEC, BENADRYL and ZANTAC were given as a treatment for the injection site rash. No lab diagnostic studies were performed. It was unknown if patient sought medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Information has been received from a female with a medical history of Shingles, high Cholesterol and high blood pressure who was vaccinated with a dose of ZOSTAVAX (Merck) in January 2009. It was reported the patient has shingles long time ago even before she received ZOSTAVAX (Merck). The patient began getting rashes between her hips and gluteus area again in February 2009 and March 2009. She continued to get shingles every month after she received ZOSTAVAX (Merck). She was even prescribed (VALTREX) which just alleviated the symptoms. The patient was not hospitalized. No further information provided. Addition information has been requested.
Falling asleep, tired, uncontrollable tongue, sleeping during the day. Weight gain.
When family members came to receive the second dose of their COVID vaccine, they informed us that the above patient had passed away.
Bleed very heavy; I essentially had 2 periods in one month, a little more than 2 weeks apart; Spotting; Painful cramping in stomach/  The cramping was more painful than normal.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Jun2021 at 08:39 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) and unspecified multivitamins; both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient reported that the first day of her menstrual cycle for June2021 was 02Jun2021 and ended on 06Jun2021. On 19Jun2021, the patient began to experience spotting and painful cramping in stomach. On 20Jun2021, the patient began to bleed very heavy. On 24Jun2021, the bleeding lessened to spotting. She does not have irregular bleeding, as cycle was normal and like clockwork. The patient essentially had 2 periods in one month, a little more than 2 weeks apart. The cramping was more painful than normal. The events did not in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of event began to bleed very heavy was resolved on 23Jun2021and began to experience spotting, had 2 periods in one month, a little more than 2 weeks apart, cramping was more painful than normal and painful cramping in stomach was resolved on an unknown date in Jun2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
It feels like I burnt my tongue.  Because of that nothing tastes the same   Still going on 3/23/21 10:54 AM  Low fever 99.9 for a couple of days  Headache, on going 3/23/21   10:54 AM  Little dizzy and weak  on going 3/23/21   10:54 AM   Nothing horrible just uncomfortable
knocked on my butt; lethargic; diarrhea; temperature of 104; threw up; This spontaneous case was reported by an other health care professional and describes the occurrence of CONFUSIONAL STATE (knocked on my butt), LETHARGY (lethargic), DIARRHOEA (diarrhea), PYREXIA (temperature of 104) and VOMITING (threw up) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Clotting disorder.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced CONFUSIONAL STATE (knocked on my butt), LETHARGY (lethargic), DIARRHOEA (diarrhea), PYREXIA (temperature of 104) and VOMITING (threw up). On 06-May-2021, VOMITING (threw up) had resolved. On 12-May-2021, CONFUSIONAL STATE (knocked on my butt), LETHARGY (lethargic), DIARRHOEA (diarrhea) and PYREXIA (temperature of 104) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She did not take any concomitant  medications or treatments.  Later in October, she experienced every single covid symptoms. She tested negative for covid twice, but did experience loss of taste and smell.   This case was linked to MOD-2022-458344 (Patient Link).
Initial consumer report received on 26 Aug 2010: This patient was on treatment with FORASEQ with a concentration of 12/400 mcg of capsules for chronic obstructive pulmonary disease for more than 3 years. Initially the posology was one inhalation with each active principle at night. Posteriorly, according medical orientation, she started to perform one inhalation with each active principle twice a day (in the morning and at night). One year ago approximately, following medical recommendation, she started to perform one inhalation with each active principle thrice a day (in the morning, in the afternoon and at night). In Jun 2010, the patient received the H1N1 vaccine (manufacturer and batch no. unknown) and 15 days after that, still in Jun 2010, she experienced pulmonary emphysema episode, shortness of breath, catarrh in the chest and difficulty to walk. These symptoms had already occurred before the treatment with the FORASEQ 12/400 mcg. Every 5 or 6 months, the patient underwent a pulmonary function test and the last test like this was scheduled to Jul 2010, but due to the pulmonary emphysema episode the physician re-scheduled it to Sep 2010. The prescriber physician oriented the patient to continue the treatment with the FORASEQ 12/400 mcg normally. The outcome of the events was reported as completely recovered.
101 fever the following day.; This is a spontaneous report from contactable healthcare professional. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6204) via an intramuscular route of administration in the right arm on 22Mar2021 at 14:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin calcium (LIPITOR) and valsartan (DIOVAN) for unknown indications from unknown dates and unknown if it was ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 23Mar2021 at 07:00, the following day of vaccine, the patient experienced a fever of 101 (units not reported). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 101 fever the following day was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Mother of Patient reports the following: within 24 hours of receiving the vaccination, pt experienced a fever of 102.8F, her O2 sats dropped to 73%, and her resting HR was 224 bbp. reports that she called Hospital and arranged to take her via ambulance to the ER but waited it out and symptoms resolved after 2 days. She gave supplemental oxygen, acetaminophen, and ibuprofen. She stated it was reminscent of when pt was hospitalized with COVID in November 2020.
Diabetes Insipidus, rare blood disorder, to much sodium in the body, and affects the kidneys